Less Ads, More Data, More Tools Register for FREE

Pin to quick picksApq Global Regulatory News (APQ)

Share Price Information for Apq Global (APQ)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 5.50
Bid: 4.00
Ask: 7.00
Change: 0.00 (0.00%)
Spread: 3.00 (75.00%)
Open: 5.50
High: 5.50
Low: 5.50
Prev. Close: 5.50
APQ Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Book Value Report

14 Jul 2023 13:00

RNS Number : 1023G
APQ Global Limited
14 July 2023
 

 

APQ Global Limited

("APQ Global" or the "Company")

 

Book value report

APQ Global is a company incorporated in Guernsey (company registration number 62008) which is listed on The International Stock Exchange and admitted to trading on AIM.

The Company hereby announces that as at the close of business on 30th June 2023, the unaudited book value per Ordinary Share was 06.98 US Dollar cents, equivalent to 05.49 Pounds Sterling pence.

 

- End -

Enquiries:

ir@apqglobal.com

IMPORTANT INFORMATION

Important Notice:

\* The term 'book value' herein includes the assets of APQ Global and its subsidiaries net of any liabilities. The figure in this announcement is an estimate and is based on unaudited estimated valuations in accordance with the Company's valuation policy as stated in the Company's AIM Admission Document. The Group has measured its private investments in accordance with IFRS 9 Financial Instruments. In September 2017, APQ Global Ltd issued 4,018 units of £5,000 nominal 3.5 per cent convertible unsecured loan stock 2024 ("CULS") to raise £20.09 million. In January 2018, APQ Global Ltd issued a further 1,982 CULS units at a price of £5,150 per £5,000 nominal to raise £10.21 million. Under IFRS, the CULS is a financial instrument and has been accounted for under IAS 32 Financial Instruments: Presentation and IFRS 9 (as effective for periods beginning on or after 1st January 2018). Therefore, the fair value of the CULS liability component has been calculated, with the difference between this and the fair value of the compound financial instrument as a whole being taken to equity. Following completion of the buy back and cancellation of CULS in April 2023, there are currently 5,920 units of CULS outstanding. Additionally, on January 28th, 2020, the Group issued 1,000,000 Warrants and 268,000 Convertible Preference Shares (CPS). In October 2021, the Group entered into an agreement to repurchase the entire amount of CPS and cancel all of the warrants outstanding. Under IFRS, the Warrants and the CPS were also Financial Instruments and were accounted for per the above guidance. This figure also includes the amounts awarded in accordance with the Company's Share-Based compensation scheme as adopted by the board on 19th April 2017 and accounted for in accordance with IFRS 2. Shares awarded under the scheme vest quarterly across 5 years. As of 30th June 2023, the total shares issued under the scheme amounted to 504,983.

Estimated results, performance or achievements may differ materially from any actual results, performance or achievements. No person has authority to give any representations or warranties (express or implied) as to, or in relation to, the accuracy, reliability or completeness of the information in this release, and all liability therefore is expressly disclaimed. Accordingly, none of the Company, the Corporate Services Provider or any of its/their respective members, directors, officers, agents, employees or advisers take any responsibility for, or will accept any liability whether direct or indirect, express or implied, contractual, tortious, statutory or otherwise, in respect of, the accuracy or completeness of the information or for any loss, howsoever arising, from the use of this release. Except as required by applicable law, the Company expressly disclaims any obligations to update or revise the above estimates to reflect any change in expectations, new information, subsequent events or otherwise.

 

 

Notes to Editors

APQ Global Limited

APQ Global (ticker: APQ LN) is an investment company incorporated in Guernsey. The Company focuses its investment activities globally (in Asia, Latin America, Eastern Europe, the Middle East, Africa and the Channel Islands, particularly).

The objective of the Company is to steadily grow its earnings to seek to deliver attractive returns and capital growth through a combination of building growing businesses as well as earning revenue from income generating operating activities in capital markets[1]. APQ Global run a well-diversified and liquid portfolio, take strategic stakes in selected businesses and plan to take operational control of companies through the acquisition of minority and majority stakes in companies with a focus on emerging markets.

1 Where we refer to revenue from income generating operating activities this relates to the revenue of our investee companies.

 


 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFZLFFXDLBBBD
Date   Source Headline
22nd Aug 20183:45 pmRNSResult of AGM
15th Aug 20187:00 amRNSBook value report
2nd Aug 20187:00 amRNSNotice of AGM
19th Jul 20187:00 amRNSQuarterly Update
19th Jul 20187:00 amRNSDividend Declaration
19th Jul 20187:00 amRNSBook value report
18th Jun 20187:00 amRNSBook value report
13th Jun 20187:00 amRNSNew appointment to Advisory Council
4th Jun 20187:00 amRNSFinal Results
15th May 20187:00 amRNSEstablishment of Partner Companies Network
15th May 20187:00 amRNSBook value report
19th Apr 20187:00 amRNSQuarterly Update
19th Apr 20187:00 amRNSDividend Declaration
19th Apr 20187:00 amRNSBook value report
21st Mar 20187:00 amRNSAppointment to Advisory Council
15th Mar 20187:00 amRNSBook Value Report
15th Feb 20187:00 amRNSBook value report
23rd Jan 20187:00 amRNSSuccessful Fundraising - Placing of £10.21 million
19th Jan 201812:20 pmRNSQuarterly Update & Outlook 2018
19th Jan 20187:00 amRNSDividend Declaration
19th Jan 20187:00 amRNSBook value report
22nd Dec 201712:00 pmRNSResult of EGM
15th Dec 20177:00 amRNSBook value report
1st Dec 201712:00 pmRNSPublication of Circular and Notice of EGM
15th Nov 20177:00 amRNSBook Value Report
31st Oct 20177:00 amRNSNew appointment to Advisory Council
19th Oct 20177:00 amRNSOutlook
19th Oct 20177:00 amRNSDividend Declaration
19th Oct 20177:00 amRNSQuarterly Update
16th Oct 20177:00 amRNSBook Value Report
12th Oct 20177:00 amRNSNew appointment to Advisory Council
9th Oct 20177:00 amRNSAdvisory Council further strengthened
26th Sep 201711:23 amRNSInterim Results for the Period to 30 June 2017
15th Sep 20177:00 amRNSBook Value Report
6th Sep 20175:00 pmRNSTrading in CULS
4th Sep 20172:00 pmRNSResults of Extraordinary General Meeting
16th Aug 20177:00 amRNS2017 Mid-Year Review
15th Aug 20177:05 amRNSSuccessful Fundraising
15th Aug 20177:00 amRNSBook Value Report
8th Aug 20173:00 pmRNSResult of AGM
8th Aug 20177:46 amRNSAppointment to the International Advisory Council
17th Jul 20177:00 amRNSQuarterly Update
17th Jul 20177:00 amRNSDividend Declaration
17th Jul 20177:00 amRNSBook Value Report
17th Jul 20177:00 amRNSPublication of Annual Report and Notice of AGM
12th Jul 20177:00 amRNSAppointments to the International Advisory Council
29th Jun 20175:56 pmRNSReport and Accounts
15th Jun 20177:00 amRNSPotential Capital Raise
15th Jun 20177:00 amRNSBook Value Report
13th Jun 20177:00 amRNSPotential Capital Raise

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.